Literature DB >> 20460532

Strategic workshops on cancer nanotechnology.

Larry A Nagahara1, Jerry S H Lee, Linda K Molnar, Nicholas J Panaro, Dorothy Farrell, Krzysztof Ptak, Joseph Alper, Piotr Grodzinski.   

Abstract

Nanotechnology offers the potential for new approaches to detecting, treating, and preventing cancer. To determine the current status of the cancer nanotechnology field and the optimal path forward, the National Cancer Institute's Alliance for Nanotechnology in Cancer held three strategic workshops, covering the areas of in vitro diagnostics and prevention, therapy and post-treatment, and in vivo diagnosis and imaging. At each of these meetings, a wide range of experts from academia, industry, the nonprofit sector, and the U.S. government discussed opportunities in the field of cancer nanotechnology and barriers to its implementation. Copyright 2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20460532      PMCID: PMC2880215          DOI: 10.1158/0008-5472.CAN-09-3716

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics.

Authors:  Chung-Cheng Lee; Guodong Sui; Arkadij Elizarov; Chengyi Jenny Shu; Young-Shik Shin; Alek N Dooley; Jiang Huang; Antoine Daridon; Paul Wyatt; David Stout; Hartmuth C Kolb; Owen N Witte; Nagichettiar Satyamurthy; James R Heath; Michael E Phelps; Stephen R Quake; Hsian-Rong Tseng
Journal:  Science       Date:  2005-12-16       Impact factor: 47.728

2.  Combinatorial ligand-directed lung targeting.

Authors:  Ricardo J Giordano; Julianna K Edwards; Rubin M Tuder; Wadih Arap; Renata Pasqualini
Journal:  Proc Am Thorac Soc       Date:  2009-08-15

3.  Steps toward mapping the human vasculature by phage display.

Authors:  Wadih Arap; Mikhail G Kolonin; Martin Trepel; Johanna Lahdenranta; Marina Cardó-Vila; Ricardo J Giordano; Paul J Mintz; Peter U Ardelt; Virginia J Yao; Claudia I Vidal; Limor Chen; Anne Flamm; Heli Valtanen; Lisa M Weavind; Marshall E Hicks; Raphael E Pollock; Gregory H Botz; Corazon D Bucana; Erkki Koivunen; Dolores Cahill; Patricia Troncoso; Keith A Baggerly; Rebecca D Pentz; Kim-Anh Do; Christopher J Logothetis; Renata Pasqualini
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

4.  Implantable diagnostic device for cancer monitoring.

Authors:  Karen D Daniel; Grace Y Kim; Christophoros C Vassiliou; Marilyn Galindo; Alexander R Guimaraes; Ralph Weissleder; Al Charest; Robert Langer; Michael J Cima
Journal:  Biosens Bioelectron       Date:  2009-04-16       Impact factor: 10.618

5.  Nanoshell-enabled photothermal cancer therapy: impending clinical impact.

Authors:  Surbhi Lal; Susan E Clare; Naomi J Halas
Journal:  Acc Chem Res       Date:  2008-12       Impact factor: 22.384

6.  Electrostatic focusing of unlabelled DNA into nanoscale pores using a salt gradient.

Authors:  Meni Wanunu; Will Morrison; Yitzhak Rabin; Alexander Y Grosberg; Amit Meller
Journal:  Nat Nanotechnol       Date:  2009-12-20       Impact factor: 39.213

7.  Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy.

Authors:  C Shad Thaxton; Robert Elghanian; Audrey D Thomas; Savka I Stoeva; Jae-Seung Lee; Norm D Smith; Anthony J Schaeffer; Helmut Klocker; Wolfgang Horninger; Georg Bartsch; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

8.  Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.

Authors:  Stephanie E A Gratton; Patrick D Pohlhaus; Jin Lee; Ji Guo; Moo J Cho; Joseph M Desimone
Journal:  J Control Release       Date:  2007-06-02       Impact factor: 9.776

9.  Iterative in situ click chemistry creates antibody-like protein-capture agents.

Authors:  Heather D Agnew; Rosemary D Rohde; Steven W Millward; Arundhati Nag; Woon-Seok Yeo; Jason E Hein; Suresh M Pitram; Abdul Ahad Tariq; Vanessa M Burns; Russell J Krom; Valery V Fokin; K Barry Sharpless; James R Heath
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

  9 in total
  4 in total

Review 1.  Convergence of nanotechnology and cancer prevention: are we there yet?

Authors:  David G Menter; Sherri L Patterson; Craig D Logsdon; Scott Kopetz; Anil K Sood; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-24

Review 2.  Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer.

Authors:  Hareesh B Nair; Bokyung Sung; Vivek R Yadav; Ramaswamy Kannappan; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2010-07-21       Impact factor: 5.858

Review 3.  National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics.

Authors:  Christopher M Hartshorn; Luisa M Russell; Piotr Grodzinski
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-07-01

4.  Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.

Authors:  Dhruba J Bharali; Murat Yalcin; Paul J Davis; Shaker A Mousa
Journal:  Nanomedicine (Lond)       Date:  2013-02-28       Impact factor: 5.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.